We treated MHCC-97 h and HCC-LM3 cells with the HDAC inhibitor suberoylanilide hydroxamic acid (SAHA) and/or the DNA methylation inhibitor 5-Aza-20-deoxycytidine (5-Aza-dc). Here, HDAC9 is linked to hepatocellular carcinoma.